The facility is designed the ease advanced therapy development and manufacturing for partners by offering closer ...

N-1 perfusion with XCell® ATF Systems increases upstream productivity and yields while using existing bioreactor ...

Industry leaders reveal how process intensification is transforming biomanufacturing with dramatic gains in yield, cost ...

The Cincinnati Children’s Center has expanded its capacity to manufacture cellular products for rare diseases.

The firm expects its investment to create 700 direct jobs by the end of 2030 while contributing 3,000 indirect jobs across ...

Discover how AI, machine learning, and multispecific designs are transforming antibody engineering, reducing development ...

We spoke to the facility’s director about the state of CGTs and how the industry can rebuild confidence in advanced ...

The Octet® R8e BLI system delivers breakthrough sensitivity for low-abundance biomolecule detection, enabling precise kinetic ...

This whitepaper examines how scalable magnetic separation technology can transform MAb production by eliminating key ...

Membrane-based chromatography matches resin-based antibody purification quality, while reducing process time, buffer use, and ...

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

Earlier this year, biotechnology company Biomar filed for voluntary bankruptcy proceedings. The company was one of the first institutions to establish itself in the Léon Technology Park in Monterrey, ...